AstraZeneca's olaparib may also work in prostate cancer -expert
November 04, 2014 at 12:05 PM EST
LONDON, Nov 4 (Reuters) - AstraZeneca's new cancer drug olaparib, which won a green light from European regulators last month for inherited ovarian cancer, could also be used much more widely to treat prostate cancer, according to a leading oncologist.
